m6A Monoklonaler Antikörper

m6A Monoklonal Antikörper für IHC, RIP, Dot Blot, ELISA, Indirect ELISA

Wirt / Isotyp

Maus / IgG3

Getestete Reaktivität

m6A

Anwendung

IHC, RIP, Dot Blot, ELISA, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1D5E10

Kat-Nr. : 68055-1-PBS

Synonyme

6-N-Methyladenoside, N6-methyladenosine



Geprüfte Anwendungen

Produktinformation

68055-1-PBS bindet in IHC, RIP, Dot Blot, ELISA, Indirect ELISA m6A und zeigt Reaktivität mit m6A

Getestete Reaktivität m6A
Wirt / Isotyp Maus / IgG3
Klonalität Monoklonal
Typ Antikörper
Immunogen Peptid
Vollständiger Name m6A
GenBank-Zugangsnummerm6A
Gene symbol
Gene ID (NCBI)
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

m6A (N6-methyladenosine) is the most abundant internal modification in mammalian mRNA. This modification is installed by the m6A methyltransferases or termed "writers"such as METTL3 and METTL14, and can be reversed by demethylases that serve as "erasers" such as FTO and ALKBH5. The stability of m6A-modified mRNA is regulated by m6A reader protein YTHDFs, which recognizes m6A and reduces the stability of target transcripts. m6A modification and its regulatory proteins play critical roles in cancer pathogenesis and progression. m6A modification is also invovled in viruses life cycles, suggesting that drugs targets to m6A pathway could be used for antiviral thereapy.

Protocol for Dot Blot:
https://www.ptglab.com/protocol/68055-1-IgDotBlot.pdf